European Drug Report 2018

European Drug Report 2018

European Drug Report 2018

What are the latest drug market trends and what are the factors driving them? What drugs are causing the most concern today? What are the most recent developments in drug prevention, treatment and policy? These, and other, questions will be explored by the EU drugs agency (EMCDDA) on 7 June in its annual overview of the European drug situation. #EDR2018

Launch details

Date: 7 June 2018
Time: 11:30 Central European Time/CET; 10:30 Western European Time/WET/Lisbon (to be confirmed) 
Venue: European Commission, Berlaymont, Brussels (to be confirmed)

Download the report

Available 7 June 2018.

Press material

Press material will be added here as it becomes available.

The European Drug Report 2018: Trends and Developments, provides a comprehensive analysis of patterns emerging across the 28 EU Member States, Turkey and Norway. In print and pdf in 24 languages, the report examines: drug supply and the market; drug use prevalence and trends; and drug-related harms and responses to them. Accompanying the report will be the 2018 Statistical Bulletin, containing the European dataset underpinning the analysis.

The report will be complemented by 30 Country Drug Reports, presenting summaries of national drug phenomena (EU-28, Turkey and Norway). Developed by the EMCDDA, in cooperation with the Reitox national focal points, these online reports cover: drug use and public health problems; drug policy and responses and drug supply.

Find out more about the launch in News release 2/2018.

Audiovisual material

Available 7 June 2018.

National launches

Available 7 June 2018.